Kamphuis, Esmé, et al. “Real-World Experience of Abrocitinib Treatment in Patients With Atopic Dermatitis and Hand Eczema: Up to 28-Week Results from the BioDay Registry”. Acta Dermato-Venereologica, vol. 104, Feb. 2024, p. adv19454, doi:10.2340/actadv.v104.19454.